Organigram Global (OGI) Competitors $1.42 +0.04 (+2.90%) Closing price 07/3/2025 03:34 PM EasternExtended Trading$1.43 +0.01 (+0.70%) As of 07/3/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OGI vs. ACB, CRON, SNDL, TLRY, VFF, MENS, REPL, VIR, SION, and GYREShould you be buying Organigram Global stock or one of its competitors? The main competitors of Organigram Global include Aurora Cannabis (ACB), Cronos Group (CRON), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Jyong Biotech (MENS), Replimune Group (REPL), Vir Biotechnology (VIR), Sionna Therapeutics (SION), and Gyre Therapeutics (GYRE). Organigram Global vs. Its Competitors Aurora Cannabis Cronos Group SNDL Tilray Brands Village Farms International Jyong Biotech Replimune Group Vir Biotechnology Sionna Therapeutics Gyre Therapeutics Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Does the media favor ACB or OGI? In the previous week, Aurora Cannabis and Aurora Cannabis both had 2 articles in the media. Organigram Global's average media sentiment score of 0.00 beat Aurora Cannabis' score of -0.17 indicating that Organigram Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, ACB or OGI? Aurora Cannabis has higher revenue and earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.04$1.63M$0.1141.59Organigram Global$117.47M1.62-$33.39M$0.1014.20 Is ACB or OGI more profitable? Organigram Global has a net margin of 8.05% compared to Aurora Cannabis' net margin of 1.32%. Aurora Cannabis' return on equity of 0.13% beat Organigram Global's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis1.32% 0.13% 0.10% Organigram Global 8.05%-5.93%-4.39% Which has more risk & volatility, ACB or OGI? Aurora Cannabis has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Do institutionals and insiders believe in ACB or OGI? 47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate ACB or OGI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67Organigram Global 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAurora Cannabis beats Organigram Global on 10 of the 14 factors compared between the two stocks. Get Organigram Global News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigram GlobalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$191.53M$10.52B$5.56B$9.04BDividend YieldN/A2.07%5.24%4.01%P/E Ratio14.2017.0327.6420.24Price / Sales1.6229.54416.55117.31Price / CashN/A22.9936.8958.10Price / Book0.693.668.035.67Net Income-$33.39M$235.40M$3.18B$249.21M7 Day Performance5.19%2.15%2.93%3.28%1 Month Performance5.19%1.07%1.72%3.95%1 Year Performance-10.41%-10.17%34.39%20.98% Organigram Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram Global0.532 of 5 stars$1.42+2.9%N/A-10.4%$191.53M$117.47M14.20860News CoverageACBAurora Cannabis0.1847 of 5 stars$4.24+2.2%N/A-5.1%$233.29M$246.72M38.551,130CRONCronos Group2.2709 of 5 stars$1.91+0.5%N/A-8.5%$732.80M$117.61M14.69450News CoverageSNDLSNDL3.54 of 5 stars$1.21-1.6%$3.63+199.6%-34.3%$323.21M$671.81M-4.172,516News CoveragePositive NewsTLRYTilray Brands1.7885 of 5 stars$0.41+3.4%$1.92+362.5%-69.3%$403.30M$788.94M-0.392,650News CoverageAnalyst DowngradeOptions VolumeVFFVillage Farms International1.0023 of 5 stars$1.10+2.8%N/A+32.3%$120.20M$336.18M-3.061,400MENSJyong BiotechN/A$8.50-10.5%N/AN/A$722.26MN/A0.0031REPLReplimune Group4.1796 of 5 stars$9.29-0.4%$20.83+124.3%+16.5%$719.22MN/A-3.03210News CoverageAnalyst ForecastVIRVir Biotechnology3.3632 of 5 stars$5.04-2.5%$32.86+551.9%-35.6%$714.69M$74.21M-1.19580News CoverageInsider TradeSIONSionna TherapeuticsN/A$17.35+9.5%$38.50+121.9%N/A$698.93MN/A0.0035Positive NewsInsider TradeGYREGyre Therapeutics0.0766 of 5 stars$7.35-0.9%N/A-34.5%$695.68M$105.76M367.6840 Related Companies and Tools Related Companies ACB Competitors CRON Competitors SNDL Competitors TLRY Competitors VFF Competitors MENS Competitors REPL Competitors VIR Competitors SION Competitors GYRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OGI) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OGI Stock Alerts